Treatment options for BCG failures.
O'Donnell
Michael A
MA
Department of Urology, University of Iowa, 200 Hawkins Dr., 3 RCP, Iowa City, IA 52242-1089, USA. michael-odonnell@uiowa.edu
Boehle
Andreas
A
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001500:BCG Vaccine / Q000494:pharmacology* / Q000627:therapeutic use; D015653:Cystectomy; D019008:Drug Resistance, Neoplasm; D004359:Drug Therapy, Combination; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D055502:Secondary Prevention; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000382:microbiology* / Q000601:surgery
D000970:Antineoplastic Agents; C087507:BCG Connaught; D001500:BCG Vaccine; D007372:Interferons